Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Elevance Health (NYSE: ELV) presented at the Barclays ... identify members with care gaps and chronic risk factors. Our care management teams then perform proactive outreach to provide early ...

Elevance Health (ELV) stock rises as CFO cites underestimated Q1 profit forecasts from analysts for the company at Barclays ...

pharmacy benefit managers, and high drug prices to make health care more affordable for Hoosiers.” That political backdrop coincides with other challenges. Late last year, Elevance endured a ...

GreensKeeper Asset Management stated the following regarding Elevance Health, Inc. (NYSE ... utilizing the company's digital solutions to improve care quality for consumers.